US Patent 10660968 Spirocyclic degronimers for target protein degradation
Patent 10660968 was granted and assigned to C4 Therapeutics on May, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10660968 Spirocyclic degronimers for target protein degradation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
